AUROPHARMANSEAurobindo Pharma Limited· PharmaceuticalsLowNeutral
Announced Fri, 19 Jun · 16:03 IST

Aurobindo Pharma promoters declare no new encumbrances for FY26

Ownership Changes View source PDF

AUROPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹1499.50
prior close
₹1498.20
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2+0.3+0.3+0.4+2.4+2.1+3.7+2.6+5.0+4.2+3.5+2.2
Up moveDown movePending
AI summary

Aurobindo Pharma's promoters have filed a SEBI disclosure confirming they created no new encumbrances (pledges or charges) on their shares during the financial year ended 31 March 2026, other than those already reported earlier. The filing includes a list of all promoters and promoter group entities. Their combined holding is about 30.09 crore shares, or 51.82% of the company's total share capital, just above the 50% mark.

Likely market impact

Routine compliance filing. No new pledges means no fresh encumbrance risk on promoter shares. Promoter stake remains comfortably above 50%.